Notice2022-22502
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 17, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 199 (Monday, October 17, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 199 (Monday, October 17, 2022)]
[Notices]
[Pages 62857-62858]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-22502]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-22CC]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Assessment for the Be Antibiotics Aware
(BAA) Consumer and Healthcare Professional Campaign'' to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on January 31, 2022, to obtain comments from
the public and affected agencies. CDC received one comment related to
the previous notice. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Assessment for the Be Antibiotics Aware (BAA) Consumer and
Healthcare Professional Campaign--New--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Antibiotic resistance (AR) is one of the most urgent threats to
public health in the United States. Antibiotic resistant bacteria have
grown more virulent, prevalent, and diverse and can spread between
human and animals. Each year there are more than 2.8 million
antibiotic-resistant infections in the United States and 35,000
individuals die as a result. At least 30% of antibiotics prescribed to
outpatients and emergency departments are unnecessary which amounts to
47 million excess prescriptions per year. One of the main side effects
of taking antibiotics is alteration of the microbiome which could lead
to infections such as C. difficile, the inability to treat infections,
prolonged illness, or even death. Risk factors for AR include lack of
knowledge, sub-therapeutic doses, excessive use, antibiotic residues,
and incorrect storage. In addition, there can be impacts on
productivity, healthcare costs, and it can serve as a drain on the
economy.
The National Action Plan calls for federal agencies to accelerate
their response to AR. The 2020-2025 National Action Plan calls for CDC
to decrease healthcare-associated AR infections by 20% by 2025 and
community-acquired AR infections by 10% by 2025. One way to decrease
the use of unnecessary antibiotic prescriptions is through antibiotic
stewardship. The goals of the Be Antibiotics Aware campaign are to seek
optimization of antibiotic prescribing and use in order to improve
patient safety and healthcare quality, and to combat AR by raising
knowledge and awareness, and motivating behavior change among consumer
and healthcare professional (HCP) audiences.
Online panel surveys will be utilized to recruit participants.
Surveys will be distributed to consumer and HCP audiences both pre- and
post-campaign. Consumer audiences include:
(1) Healthy adults who visit urgent care, ages 18-64,
(2) Community dwelling older adults, ages 65+, and
(3) Family caregivers of nursing home (long-term care) residents.
HCP audiences include:
(1) Hospitalists,
(2) Dentists,
(3) Community pharmacists,
(4) Physicians and advanced practice providers in nursing homes,
and
(5) Nurses in nursing homes.
[[Page 62858]]
This program evaluation will assist CDC in determining if the Be
Antibiotics Aware media campaign, along with partner outreach, was
successful in raising knowledge and awareness and motivating behavior
change among the intended consumer and HCP audiences in select markets.
The information gathered from this evaluation will also be used to
inform refinement and implementation of the campaign (materials and
tactics).
CDC requests OMB approval for an estimated 842 annual burden hours.
There is no cost to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Consumer Audiences.................... BAA Consumer Pre- 473 1 20/60
Campaign Web Survey.
Consumer Audiences.................... BAA Consumer Post- 473 1 20/60
Campaign Web Survey.
HCP Audiences......................... BAA HCP................. 788 1 20/60
Consumer Audiences.................... BAA Consumer Pre- 473 1 20/60
Campaign Web Survey.
Pre-Campaign Web Survey. .............. .............. ..............
HCP Audiences......................... BAA HCP Post-Campaign 788 1 20/60
Web Survey.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-22502 Filed 10-14-22; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on October 17, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.